Last reviewed · How we verify

NCT03920943: TAT

Temporal Artery Thermometer in Patient Transport: Reliability and Validity.

Withdrawn NA Last updated 4 March 2021
What this trial tests

NA trial testing Measurement of temperature using non-invasive means in Body Temperature. Withdrawn.

Timeline
1 September 2019
Primary endpoint
31 December 2020
30 June 2021

Quick facts

Lead sponsorOrnge Transport Medicine
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Start date1 September 2019
Primary completion31 December 2020
Estimated completion30 June 2021
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Ornge Transport Medicine

Who can join

Eligibility, any sex, with Body Temperature. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the reliability and validity of temperature measurements using an existing, Health Canada-approved, non-invasive temporal artery thermometer, and comparing results to an established, invasive gold standard (esophageal probe), in order to assess reliability of this non-invasive method to measure core body temperature in the setting of patients undergoing inter-facility patient transport by land, rotor-wing, and fixed-wing transport vehicles.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Body Temperature

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03920943.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing